Fluralaner CAS#864731-61-3
Systemic Insecticidal and Acaricidal Activity: Provides effective systemic control against fleas and ticks through oral administration, offering reliable parasite protection.
Long-Lasting Parasite Control: Delivers sustained efficacy for the prevention and treatment of flea and tick infestations in dogs.
Globally Approved Veterinary Application: Approved by regulatory authorities including the U.S. FDA, European Union, and Australia for veterinary use in dogs.
Convenient Oral Administration: Provides an easy-to-use oral treatment option, improving compliance and simplifying parasite management for pet owners.
Fluralaner CAS#864731-61-3
Fluralaner (INN) is an orally administered systemic insecticide and acaricide. In May 2014, the U.S. Food and Drug Administration (FDA) approved Fluralaner under the trade name Bravecto for the treatment of flea infestations in dogs. The European Union approved the product in February 2014, and Australia approved its use in January 2015 for the treatment and prevention of tick and flea infestations in dogs.
Fluralaner Chemical Properties
| density | 1.51±0.1 g/cm3(Predicted) |
| storage temp. | Store at -20°C |
| solubility | DMSO:150.0(Max Conc. mg/mL);269.65(Max Conc. mM) |
| Ethanol:25.0(Max Conc. mg/mL);44.94(Max Conc. mM) | |
| form | A crystalline solid |
| pka | 12.50±0.46(Predicted) |
| color | White to off-white |
| InChIKey | MLBZKOGAMRTSKP-UHFFFAOYSA-N |
| SMILES | C(NCC(=O)NCC(F)(F)F)(=O)C1=CC=C(C2CC(C3=CC(Cl)=CC(Cl)=C3)(C(F)(F)F)ON=2)C=C1C |
Product Application of Fluralaner CAS#864731-61-3
Fluralaner (CAS#864731-61-3) is a novel systemic insecticide and acaricide that provides long-lasting efficacy when administered orally to dogs. As a member of the isoxazoline class of compounds, Fluralaner offers effective control against fleas and ticks.
Clinical field studies have demonstrated that a single oral dose of Fluralaner can provide at least 12 weeks of protection against flea and tick infestations in dogs. Its extended duration of action provides a more convenient alternative to monthly flea and tick treatments, improving treatment compliance and helping reduce the risk of vector-borne diseases.
